​eXeBlock Appoints New President and Chief Executive Officer

Spotlight Companies  |

eXeBlock Technology Corporation ( (XBLK:CNX)) is pleased announce that the Board of Directors has appointed Mr. Jamie Davison as the new President and Chief Executive Officer of the Company, effective immediately. Mr. Davison replaces Mr. Ian Klassen who will remain a member of the Board of Directors and will continue to advise the Company on an ongoing basis.

Mr. Davison brings extensive operating and executive leadership experience to the team, highlighted by his strong track record of value creation and his depth of knowledge in commercializing innovation technology. Most recently, Mr. Davison served as Vice President, Innovation and Renewal at the Atlantic Lottery Corporation where he was responsible for managing and directing the Innovation group which was comprised of a research arm focused on the 4D development process, a development team launching MVP's and internal innovation and culture initiatives. Mr. Davison, an Economics graduate from Acadia University, will be based in Halifax where he will utilize his results driven skills to carry on the Company's business model of DApp development and commercialization.

"This is the perfect time for Jamie to become eXeblock's new Chief Executive Officer. We've selected a very strong leader at a time when eXeBlock anticipates the launch of several exciting decentralized applications," said Paul Thompson, Director of eXeBlock. "The adoption of blockchain applications is growing exponentially. Companies and individuals all over the world are attempting to understand the disruptive potential of blockchain applications. Jamie will play a key role in navigating eXeBlock's transformation from development to commercial operations. We believe Jamie has a unique ability to translate the Company's vision and strategy into execution while building an innovative team and environment to drive results."

"On behalf of eXeBlock and the Board of Directors, we would like to thank Mr. Klassen for his dedication and significant contribution to the Company."

Lastly, the Company is pleased to announce that subject to regulatory approval, it has granted incentive stock options to Mr. Davison, to purchase up to 500,000 common shares exercisable on or before June 21, 2023 at a price of $0.15 per share.

About eXeBlock Technology Corporation

eXeBlock is a designer of custom, state-of-the-art blockchain based software applications that provide profitable, secure and efficient operating solutions to businesses and markets globally. eXeBlock is one of the first Canadian public companies focused on the development of disruptive decentralized applications using blockchain technology.

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
XBLK:CNX eXeBlock Technology Corp - Ordinary Shares 0.05 0.00 0.00 78,485


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.